Slowly Signaling G Protein-Biased CB<sub>2</sub> Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence.
作者:
主题词
镇痛药, 阿片类(Analgesics, Opioid);动物(Animals);抗肿瘤药(Antineoplastic Agents);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物耐受性(Drug Tolerance);GTP结合蛋白质类(GTP-Binding Proteins);HEK293细胞(HEK293 Cells);人类(Humans);男(雄)性(Male);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);小鼠, 基因敲除(Mice, Knockout);吗啡(Morphine);吗啡依赖(Morphine Dependence);纳洛酮(Naloxone);麻醉品拮抗药(Narcotic Antagonists);神经痛(Neuralgia);紫杉酚(Paclitaxel);嘌呤类(Purines);受体, 大麻酚, CB2(Receptor, Cannabinoid, CB2);信号传导(Signal Transduction);物质戒断综合征(Substance Withdrawal Syndrome)
DOI
10.1124/mol.117.109355
PMID
29192123
发布时间
2025-02-13
- 浏览4

Molecular pharmacology
49-62页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文